4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes

Clinical trial NCT00558571 · COMPLETED

Trial details

NCT number: NCT00558571
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-01-01
Primary completion: 2008-04-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.